FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: PRESCRIPTION DRUG USER FEE ACT; STAKEHOLDER CONSULTATION MEETINGS ON THE PRESCRIPTION DRUG USER FEE ACT REAUTHORIZATION; REQUEST FOR NOTIFICATION OF STAKEHOLDER INTENTION TO PARTICIPATE

WASHINGTON, May 9 -- Food and Drug Administration has issued a notice called: Prescription Drug User Fee Act; Stakeholder Consultation Meetings on the Prescription Drug User Fee Act Reauthorization; Request for Notification of Stakeholder Intention To Participate.

The notice was published in the Federal Register on May 9 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.

Summary: The Food and Drug Administration (FDA or Agency) is issuing this notice to request that public stakeholders-including patient and consumer advocacy groups, healthcare professionals, and scientific and academic experts-notify FDA of their intent to participate in periodic consultation meetings on the reauthorization of the ...